Tour DaVita Raises $1 Million for The Kidney TRUST

  Tour DaVita Raises $1 Million for The Kidney TRUST

       Organization Will Use Funds to Support Kidney Screening Program

Business Wire

DENVER -- October 15, 2013

DaVita®, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a
leading provider of kidney care services, today announced that the seventh
annual Tour DaVita® raised $1 million for The Kidney TRUST™.

Tour DaVita is a three-day, 220-mile bike ride to raise awareness and funds
for the fight against kidney disease. This year’s beneficiary, The Kidney
TRUST, is a 501(c)(3) independent nonprofit organization that seeks to reduce
the progression of chronic kidney disease through a no-cost, rapid screening
in non-medical settings.

“The funds from this year’s Tour DaVita will go a long way in supporting our
mission,” said Gloria Upchurch, program manager of The Kidney TRUST. “We will
be able to continue helping communities around the country better understand
their kidney health, including kidney disease risk factors.”

More than 250 Tour DaVita participants had their kidneys screened at no cost
by The Kidney TRUST during this year’s event. It is estimated that one in 10
U.S. adults over the age of 20 has kidney disease, but may not be aware of it.
In support of raising awareness, DaVita created an online risk quiz for people
to learn about their kidney health.

Tour DaVita 2013 was held in upstate South Carolina with 570 participants
cycling from Gaffney to Chester on day one; from Chester to Fountain Inn on
day two; and from Fountain Inn to Seneca on day three.

To participate in Tour DaVita, riders each raised a minimum of $750 in
donations and paid their own travel expenses. Corporate sponsors also
contributed to the fundraising efforts.

To date, Tour DaVita has helped raise more than $5 million for nonprofits
dedicated to raising awareness for kidney disease, providing kidney screenings
and expanding access to dialysis care in developing countries. Participants
have collectively ridden more than 533,000 miles over the course of seven

Corporate sponsors for this year’s Tour DaVita included Amgen, ASD Healthcare,
Baxter International Inc., Golden Construction Development Company, Inc. and
NxStage Medical, Inc.

To find a no-cost screening near you, visit

For more information about the seventh annual Tour DaVita, please visit For more information about The Kidney TRUST, please visit

DaVita and Tour DaVita are registered trademarks of DaVita HealthCare Partners
Inc. All other trademarks are the property of their respective owners.

About DaVita

DaVita is the dialysis division of DaVita HealthCare Partners Inc., a Fortune
500® company that, through its operating divisions, provides a variety of
health care services to patient populations throughout the United States and
abroad. A leading provider of kidney care in the United States, DaVita
delivers dialysis services to patients with chronic kidney failure and end
stage renal disease. DaVita strives to improve patients’ quality of life by
innovating clinical care, and by offering integrated treatment plans,
personalized care teams and convenient health-management services. As of June
30, 2013, DaVita operated or provided administrative services at 2,010
outpatient dialysis centers located in the United States serving approximately
159,000 patients. The company also operates 48  outpatient dialysis centers
located in ten countries outside the United States. DaVita supports numerous
programs dedicated to creating positive, sustainable change in communities
around the world. The company’s leadership development initiatives and social
responsibility efforts have been recognized by Fortune, Modern Healthcare,
Newsweek and WorldBlu. For more information, please visit

About The Kidney TRUST

Founded in 2006, The Kidney TRUST is a national non-profit organization
dedicated to reducing the human and economic cost of kidney disease. The
Kidney TRUST is focused on increasing awareness of chronic kidney disease
(CKD) through public education and early-detection testing programs so that
progression of CKD to kidney failure can be delayed or prevented. The Kidney
TRUST is also developing innovative solutions to address the critical unmet
needs of people with CKD. Visit for more information.


Bianca Violante, 303-876-6614
Press spacebar to pause and continue. Press esc to stop.